Unlike gene therapy, where a virus serves as a carrier for transgene delivery, this therapeutic approach utilizes the virus itself as an active drug reagent.
https://www.google.com/url?rct=j&sa=t&url=https://www.onclive.com/view/japanese-approval-sought-for-oncolytic-virus-teserpaturev-for-malignant-glioma&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNEpt4Y-BlNzUG7EBupejuBIgFzRAg
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.